WATCHMAN FLX Device Brief Summary WATCHMAN FLX Pro Device Brief Summary SH-853601-AJ
clinical trials Safe2 99% implant success rate* 0.5% major adverse event rate† Effective2 96.2% of patients discontinued OACs at 45 days Protect your patients: stroke risk reduction without the risks of OACs Learn more about the WATCHMAN Implant and hear from cardiologists on this safe, OA...
Safety of percutaneous left atrial appendage closure: results from the Watchman left atrial appendage system for embolic protection in patients with AF (PROTECT AF) clinical trial and the continued access registry Circulation, 123 (2011), pp. 417-424 Google Scholar 13 S.E. Kasner Clinical interpre...
Summary 付属のビデオは心耳(LAA)デバイスを左夜警の経皮的配置の手順について説明します。警備員は、彼らが血栓塞栓性脳卒中を防ぐために、LAAを終了する前に血栓をトラップするニチノール永久に移植するように設計され、デバイス、またはわずかに遠位、左心耳(LAA)の開口である。 Abstract 心房細...